Quimi Daphne
SEC insider (Form 3/4/5 filer). CIK 0001543031. Director at Century Therapeutics, Inc. (IPSC) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in CAMBRIDGE, MA.
Companies Quimi Daphne has filed insider reports for
- Century Therapeutics, Inc. (IPSC): Director
- Amylyx Pharmaceuticals, Inc. (AMLX): Director
Quimi Daphne
CIK: 0001543031
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 11, 2026IPSC
Century Therapeutics, Inc.
AwardDirectStock Option (right to buy)
74K shares- - Jun 4, 2026AMLX
Amylyx Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
24.4K shares- - Jun 12, 2025IPSC
Century Therapeutics, Inc.
AwardDirectStock Option (right to buy)
44K shares- - Jun 5, 2025AMLX
Amylyx Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
25K shares- - Sep 12, 2024IPSC
Century Therapeutics, Inc.
PurchaseDirect5K shares at avg. $1.53$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  IPSC Century Therapeutics, Inc. | Award Stock Option (right to buy) | 74,000 | - | - | Direct |
| Jun 4, 2026 |  AMLX Amylyx Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 24,372 | - | - | Direct |
| Jun 12, 2025 | IPSC Century Therapeutics, Inc. | Award Stock Option (right to buy) | 44,000 | - | - | Direct |
| Jun 5, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 25,000 | - | - | Direct |
| Sep 12, 2024 | IPSC Century Therapeutics, Inc. | Purchase | 5,000 | $1.53 | $7,657 | Direct |
1-5 of 5 transactions